These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1677248)

  • 1. Caudate hyperintensities in elderly depressed patients with neuroleptic-induced parkinsonism.
    Figiel GS; Krishnan KR; Doraiswamy PM; Nemeroff CB
    J Geriatr Psychiatry Neurol; 1991; 4(2):86-9. PubMed ID: 1677248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic induced parkinsonism: MRI findings in relation to clinical course after withdrawal of neuroleptic drugs.
    Bocola V; Fabbrini G; Sollecito A; Paladini C; Martucci N
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):213-6. PubMed ID: 8708659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caudate nucleus area in drug-induced parkinsonism.
    Brown KW; Wardlaw JM; White T; Walker N
    Acta Psychiatr Scand; 1996 Nov; 94(5):348-51. PubMed ID: 9124082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent.
    Heitmiller DR; Nopoulos PC; Andreasen NC
    Schizophr Res; 2004 Feb; 66(2-3):137-42. PubMed ID: 15061245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in caudate volume with neuroleptic treatment.
    Keshavan MS; Bagwell WW; Haas GL; Sweeney JA; Schooler NR; Pettegrew JW
    Lancet; 1994 Nov; 344(8934):1434. PubMed ID: 7968091
    [No Abstract]   [Full Text] [Related]  

  • 6. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.
    McClure RK; Carew K; Greeter S; Maushauer E; Steen G; Weinberger DR
    Schizophr Res; 2008 Jan; 98(1-3):29-39. PubMed ID: 17976957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome?
    Melamed E; Achiron A; Shapira A; Davidovicz S
    Clin Neuropharmacol; 1991 Jun; 14(3):273-8. PubMed ID: 1676933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-induced parkinsonian side effects in the mentally handicapped.
    Rao JM; Cowie VA; Mathew B
    J Ment Defic Res; 1989 Feb; 33 ( Pt 1)():81-6. PubMed ID: 2564436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic-induced parkinsonism in older schizophrenics.
    Hoffman WF; Labs SM; Casey DE
    Biol Psychiatry; 1987 Apr; 22(4):427-39. PubMed ID: 2882787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia.
    Okugawa G; Nobuhara K; Takase K; Saito Y; Yoshimura M; Kinoshita T
    Neuropsychobiology; 2007; 55(1):43-6. PubMed ID: 17556852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
    Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
    Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic-induced parkinsonism is associated with olfactory dysfunction.
    Krüger S; Haehner A; Thiem C; Hummel T
    J Neurol; 2008 Oct; 255(10):1574-9. PubMed ID: 18769856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI abnormalities in tardive dyskinesia.
    Mion CC; Andreasen NC; Arndt S; Swayze VW; Cohen GA
    Psychiatry Res; 1991 Nov; 40(3):157-66. PubMed ID: 1685788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased caudate volume in neuroleptic-naive psychotic patients.
    Keshavan MS; Rosenberg D; Sweeney JA; Pettegrew JW
    Am J Psychiatry; 1998 Jun; 155(6):774-8. PubMed ID: 9619149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible drug-induced parkinsonism. Clinicopathologic study of two cases.
    Rajput AH; Rozdilsky B; Hornykiewicz O; Shannak K; Lee T; Seeman P
    Arch Neurol; 1982 Oct; 39(10):644-6. PubMed ID: 6127066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?
    Lim TT; Ahmed A; Itin I; Gostkowski M; Rudolph J; Cooper S; Fernandez HH
    Int J Neurosci; 2013 Mar; 123(3):170-4. PubMed ID: 23078283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic treatment and caudate plasticity.
    Doraiswamy PM; Tupler LA; Krishnan KR
    Lancet; 1995 Mar; 345(8951):734-5. PubMed ID: 7885157
    [No Abstract]   [Full Text] [Related]  

  • 18. MRI in tardive dyskinesia: shortened left caudate T2.
    Bartzokis G; Garber HJ; Marder SR; Olendorf WH
    Biol Psychiatry; 1990 Dec; 28(12):1027-36. PubMed ID: 1981152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcortical hyperintensities on brain magnetic resonance imaging: a comparison between late age onset and early onset elderly depressed subjects.
    Figiel GS; Krishnan KR; Doraiswamy PM; Rao VP; Nemeroff CB; Boyko OB
    Neurobiol Aging; 1991; 12(3):245-7. PubMed ID: 1876230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic-induced Parkinsonism: Clinicopathological study.
    Shuaib UA; Rajput AH; Robinson CA; Rajput A
    Mov Disord; 2016 Mar; 31(3):360-5. PubMed ID: 26660063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.